NTLA (STOCKS)
Intellia Therapeutics, Inc
$12.000000
+0.090000 (+0.76%)
Prev close: $11.910000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- John M. Leonard
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,388.80M
- Employees
- 598
- P/E (TTM)
- -2.81
- P/B (TTM)
- 1.84
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
10
Buy
13
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.92 | $-1.02 | +0.1019 | +9.97% |
|
Jun 2025 (Q2)
|
$-0.98 | $-1.04 | +0.0582 | +5.61% |
|
Mar 2025 (Q1)
|
$-1.10 | $-1.31 | +0.2082 | +15.92% |
|
Dec 2024 (Q4)
|
$-1.27 | $-1.36 | +0.0859 | +6.34% |
Financial Statements
| Assets | $925.28M |
| Current Assets | $581.94M |
| Noncurrent Assets | $343.33M |
| Fixed Assets | $20.42M |
| Other Non-current Assets | $322.91M |
| Liabilities | $176.85M |
| Current Liabilities | $93.73M |
| Accounts Payable | $13.26M |
| Wages | $16.83M |
| Other Current Liabilities | $63.64M |
| Noncurrent Liabilities | $83.13M |
| Equity | $748.42M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $748.42M |
| Liabilities And Equity | $925.28M |